-
Mashup Score: 0What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, discusses the phase 3 PEACE study, testing pegzilarginase to treat arginase 1 deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, discusses the phase 3 PEACE study, testing pegzilarginase to treat arginase 1 deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, discusses the phase 3 PEACE study, testing pegzilarginase to treat arginase 1 deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What Is Arginase 1 Deficiency? - 2 year(s) ago
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, gives an overview of Arginase 1 (ARG1) deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr Anthony Quinn, CEO of Aeglea BioTherapeutics, discusses the phase 3 PEACE study, testing pegzilarginase to treat arginase 1 deficiency.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Anthony Quinn, PhD, President and CEO of Aeglea BioTherapeutics, provides an overview of Arginase 1 #ARG1 deficiency. @aegleabio https://t.co/5Pp4rhy4oi